Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-04
DOI
10.1111/bcp.14690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase®
- (2020) Basile Chrétien et al. PSYCHOLOGICAL MEDICINE
- Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database
- (2020) Putkaradze Zaza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Drug repositioning: a brief overview
- (2020) Jean‐Pierre Jourdan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Case–non-case studies: Principle, methods, bias and interpretation
- (2019) Jean-Luc Faillie THERAPIE
- Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study
- (2018) Nicole Eady et al. BRITISH JOURNAL OF PSYCHIATRY
- Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities
- (2018) Damijan Knez et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid
- (2018) Gary Tin et al. ACS Chemical Neuroscience
- An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs
- (2018) Kouichi Hosomi et al. PLoS One
- In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
- (2018) Raimunda S. S. Azevedo et al. Scientific Reports
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- New Martian valley network volume estimate consistent with ancient ocean and warm and wet climate
- (2017) Wei Luo et al. Nature Communications
- Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
- (2017) Eric Wen Su et al. PeerJ
- Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease
- (2016) Sultan Darvesh Current Alzheimer Research
- Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
- (2016) Kejian Wang et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- A cholinergic basal forebrain feeding circuit modulates appetite suppression
- (2016) Alexander M. Herman et al. NATURE
- A Tool to Utilize Adverse Effect Profiles to Identify Brain-Active Medications for Repurposing
- (2015) T. H. McCoy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Systematic Drug Repositioning for a Wide Range of Diseases with Integrative Analyses of Phenotypic and Molecular Data
- (2015) Hiroaki Iwata et al. Journal of Chemical Information and Modeling
- Clinical-pathologic study of depressive symptoms and cognitive decline in old age
- (2015) H. Kunte et al. NEUROLOGY
- Use of Logistic Regression to Combine Two Causality Criteria for Signal Detection in Vaccine Spontaneous Report Data
- (2014) Lionel Van Holle et al. DRUG SAFETY
- Exploring the associations between drug side-effects and therapeutic indications
- (2014) Fei Wang et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
- (2014) Hao Ye et al. PLoS One
- Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
- (2014) C. Lecoutey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
- (2011) Jean-Louis Montastruc et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer’s disease
- (2011) B. Tasso et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports
- (2011) Nicholas P Tatonetti et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- How were new medicines discovered?
- (2011) David C. Swinney et al. NATURE REVIEWS DRUG DISCOVERY
- Systematic Drug Repositioning Based on Clinical Side-Effects
- (2011) Lun Yang et al. PLoS One
- Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans
- (2011) J. R. Cirrito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database
- (2008) A. Bate et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Anticholinergic Activity of 107 Medications Commonly Used by Older Adults
- (2008) Marci L. Chew et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Drug Target Identification Using Side-Effect Similarity
- (2008) M. Campillos et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search